• 98 Citations
  • 4 h-Index
20182019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Massimiliano Mirabella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Multiple Sclerosis Medicine & Life Sciences
Relapsing-Remitting Multiple Sclerosis Medicine & Life Sciences
sclerosis Agriculture & Biology
Propensity Score Medicine & Life Sciences
Brain-Derived Neurotrophic Factor Medicine & Life Sciences
disease course Agriculture & Biology
methylation Agriculture & Biology
Methylation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2018 2019

  • 98 Citations
  • 4 h-Index
  • 16 Article
  • 1 Comment/debate

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

Vanoli, E., Montano, N., De Angelis, G., Badilini, F., Mirabella, M., Bonavita, S., Patti, F., Bianco, A., Sparaco, M., Chisari, C., Laroni, A., Frigerio, F., Bartezaghi, M., Rossi, S., Turrini, R. & Mancardi, G., 2019, In : Journal of the Neurological Sciences. 405, 116423.

Research output: Contribution to journalArticle

Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

Vanoli, E., Montano, N., De Angelis, G., Badilini, F., Mirabella, M., Bonavita, S., Patti, F., Bianco, A., Sparaco, M., Chisari, C., Laroni, A., Frigerio, F., Bartezaghi, M., Rossi, S., Turrini, R. & Mancardi, G., Oct 15 2019, In : Journal of the Neurological Sciences. 405, 116423.

Research output: Contribution to journalArticle

Relapsing-Remitting Multiple Sclerosis
Electrocardiography
Heart Rate
Sphingosine
Fingolimod Hydrochloride

Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140)

Nociti, V., Santoro, M., Quaranta, D., Losavio, F. A., De Fino, C., Giordano, R., Palomba, N. P., Rossini, P. M., Guerini, F. R., Clerici, M., Caputo, D. & Mirabella, M., Feb 1 2019, In : PLoS One. 14, 2, e0212906.

Research output: Contribution to journalComment/debate

Open Access
Methylation
Brain-Derived Neurotrophic Factor
sclerosis
Polymorphism
disease course

Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Clerico, M., De Mercanti, S. F., Signori, A., Iudicello, M., Cordioli, C., Signoriello, E., Lus, G., Bonavita, S., Lavorgna, L., Maniscalco, G. T., Curti, E., Lorefice, L., Cocco, E., Nociti, V., Mirabella, M., Baroncini, D., Mataluni, G., Landi, D., Petruzzo, M., Lanzillo, R. & 8 others, Gandoglia, I., Laroni, A., Frangiamore, R., Sartori, A., Cavalla, P., Costantini, G., Sormani, M. P. & Capra, R., Jan 1 2019, (Accepted/In press) In : Neurotherapeutics.

Research output: Contribution to journalArticle

Progressive Multifocal Leukoencephalopathy
Natalizumab
Appointments and Schedules
Cohort Studies
Retrospective Studies

The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray)

Grimaldi, A. E., De Giglio, L., Haggiag, S., Bianco, A., Cortese, A., Crisafulli, S. G., Monteleone, F., Marfia, G., Prosperini, L., Galgani, S., Mirabella, M., Centonze, D., Pozzilli, C. & Castelli, L., Jan 1 2019, In : PLoS One. 14, 7, e0219670.

Research output: Contribution to journalArticle

Open Access
physical therapy
Physical therapy
Dronabinol
sclerosis
Multiple Sclerosis